Traduction de «Vaccination par instillation dans l'œil » (Français → Anglais) :

Question No. 446 Ms. Kirsty Duncan: With respect to the current pandemic of new influenza A (H1N1): (a) what is the key leadership shown by the organizational reporting chart, from the two lead ministries, the Public Health Agency of Canada and Public Safety Canada, through to the deputy ministers; (b) what is the decision-making process to determine which of the two ministries leads on issues; (c) what, if any, funding requests have been made by government departments for pandemic planning since the beginning of the pandemic in Canada; (d) what, if any, additional funding is required to ensure all government departments have tested their H1N1 plans and rolle ...[+++]d them out to their employees; (e) what, if any, specific agreements have been signed with the provinces and territories, and which, if any, agreements still need to be signed; (f) what are the government’s identified critical services, what is the decision-making process to reduce services if required, and who has responsibility for these decisions; (g) how will the government acquire and distribute medical countermeasures if required; (h) what guidance is being provided to foreign missions, including consulates, embassies, high commissions and trade offices, and what is the decision-making process to reduce services, or repatriate staff; (i) what guidance is being provided to the Canadian Forces, including the army, the air force and the navy, and what recommendations are being made for military personnel; (j) with regard to recommendations being made to the Canadian Forces and military personnel concerning vaccinations, what processes are in place to (i) re-evaluate policies as required, (ii) ensure legal compliance and respect ethical considerations, (iii) ensure protection of our troops in Afghanistan; (k) on what date was the pandemic vaccine ordered, and what, if any, effect did having only one supplier, or the decision to use adjuvant, had on the delivery date for the H1N1 vaccine; (l) what, i ...

(Return tabled) Question No. 242 Mr. Peter Stoffer: With regard to the anthrax vaccine administered to Canadian Forces personnel serving in the Gulf War: (a) has the government completed independent testing on the safety of the vaccine; (b) has the government completed a study on the health of Canadian Forces personnel who received the vaccine; and (c) has the government continued to monitor or has it undertaken any follow up studies on the health of Canadian Forces personnel who have received the vaccine?

Both Member States outlined the monitoring and control measures that would be followed with regard to the vaccinated birds. These include the use of sentinel birds (i.e. unvaccinated control birds) to monitor for an avian influenza outbreak in the vaccinated flock, regular testing of the vaccinated and sentinel birds, and the continued application of bio-security provisions already in place.

—For novel vaccines, which contain a novel vaccine antigen, the applicant shall submit to a competent authority a full marketing-authorisation application dossier including all the Vaccine Antigen Master Files corresponding to each single vaccine antigen that is part of the novel vaccine where no master file already exists for the single vaccine antigen.

The marketing authorisation application dossier of a vaccine other than human influenza vaccine, shall be required to include a Vaccine Antigen Master File for every vaccine antigen that is an active substance of this vaccine.

—By derogation from the provisions of the first, second and third indents of the present point (evaluation and certification), where a Vaccine Antigen Master File corresponds only to a vaccine which is the subject of a marketing authorisation which has not been/will not be granted according to a Community procedure, and, provided the authorised vaccine includes vaccine antigens which have not been evaluated through a Community procedure, the scientific and technical evaluation of the said Vaccine Antigen Master File and its subsequent changes, shall be carried out by the nati ...[+++]onal competent authority that has granted the marketing authorisation.